Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Qorvo (QRVO) stock drops 8% as Apple-linked chip names slide ahead of U.S. jobs report

Qorvo (QRVO) stock drops 8% as Apple-linked chip names slide ahead of U.S. jobs report

New York, Jan 7, 2026, 13:45 EST — Regular session Qorvo shares fell about 8% on Wednesday, underperforming a mixed U.S. market as investors trimmed exposure to smaller chipmakers. The stock was down $7.36 at $80.76, after touching a session low of $79.76. The drop mattered because it hit a corner of semiconductors tied to phone demand just as broader indexes leaned on megacap tech again. “The economic news sort of fueled a little bit of profit taking,” Robert Pavlik, senior portfolio manager at Dakota Wealth, said of the day’s trading. Reuters Fresh labor data added to the push-and-pull over
7 January 2026
······
AST SpaceMobile stock dives 10% as Scotiabank downgrade hits ASTS valuation

AST SpaceMobile stock dives 10% as Scotiabank downgrade hits ASTS valuation

New York, January 7, 2026, 13:29 EST — Regular session AST SpaceMobile (ASTS) shares fell 10.2% to $87.55 in regular trading on Wednesday after Scotiabank cut its rating. The stock has traded between $95.25 and $86.20 so far, with about 15 million shares changing hands. Finviz Scotiabank analyst Andres Coello downgraded the stock to “Sell” and set a $45.60 price target, Barron’s reported. Coello flagged valuation, with the stock trading at more than 100 times projected 2026 sales and about 20 times estimated 2029 EBITDA, even as the company is not expected to post positive operating profits until 2027, the
7 January 2026
·····
Fermi Inc stock slides 10% on fresh class-action filing headlines, with Evercore conference next

Fermi Inc stock slides 10% on fresh class-action filing headlines, with Evercore conference next

New York, January 7, 2026, 13:24 (EST) — Regular session Shares of Fermi Inc (FRMI.O) slid on Wednesday, last down $1.01, or about 10.6%, at $8.50. The stock hit an intraday low of $8.37 and had traded about 5.6 million shares. The move came as plaintiffs’ firms pushed fresh notices around a proposed securities class action lawsuit, reopening questions about how Fermi pitched demand and funding for its Project Matador campus in Texas. Glancy Prongay & Murray said the case targets investors who bought stock in or traceable to the October IPO, priced at $21 a share, or bought securities
7 January 2026
····
Skyworks Solutions stock tumbles nearly 12% in regular session as SWKS slides on CES week

Skyworks Solutions stock tumbles nearly 12% in regular session as SWKS slides on CES week

New York, Jan 7, 2026, 13:25 ET — Regular session Skyworks Solutions shares were down 11.8% at $58.44 in afternoon trade on Wednesday, after touching an intraday low of $58.17. No immediate catalyst was apparent. The selloff comes as the chipmaker works to convince investors it can lean more on markets beyond smartphones, with CES 2026 in full swing. “As AI accelerates at the edge, Skyworks delivers high-performance technologies that move data, synchronize intelligent systems,” Yusuf Jamal, a senior vice president at the company, said in a CES-related release. Nasdaq That push sits alongside a bigger overhang: Skyworks’ planned cash-and-stock
7 January 2026
····
Viasat stock slides as Evergreen signs on for Inmarsat NexusWave, CFO sale hits tape

Viasat stock slides as Evergreen signs on for Inmarsat NexusWave, CFO sale hits tape

New York, January 7, 2026, 13:26 EST — Regular session Viasat shares fell $4.89, or about 11.3%, to $38.57 on Wednesday, a day after the stock closed at $43.46. The shares traded between $38.27 and $43.58. The drop comes as investors weigh whether Viasat’s Inmarsat business can keep landing big mobility customers that buy recurring service, not just hardware. Maritime contracts matter because they can be sticky, with ships typically locked into connectivity providers for years. That is a key question for Viasat heading into its next results, as the company tries to show steady demand across its mobility products
7 January 2026
·····
Why Wave Life Sciences (WVE) stock is up today after Arrowhead’s obesity data spotlights INHBE

Why Wave Life Sciences (WVE) stock is up today after Arrowhead’s obesity data spotlights INHBE

New York, Jan 7, 2026, 12:57 (EST) — Regular session Wave Life Sciences shares rose 4.4% to $15.82 in midday trade on Wednesday. The stock has stayed in motion as investors circle back to obesity plays tied to a gene target called INHBE. The spark this week came from Arrowhead Pharmaceuticals, which on Tuesday posted interim results from its obesity candidates aimed at INHBE or its receptor, ALK7. Arrowhead said its ARO-INHBE nearly doubled weight loss when paired with Eli Lilly’s tirzepatide, and drove what an outside expert called “dramatic and rapid reductions in visceral fat,” the fat that builds
7 January 2026
·····
Ambarella stock dives as AMBA reverses after CES CV7 chip and DevZone launch

Ambarella stock dives as AMBA reverses after CES CV7 chip and DevZone launch

NEW YORK, Jan 7, 2026, 13:14 EST — Regular session Ambarella, Inc. shares were down 12.5% at $70.54 in early afternoon trading on Wednesday after swinging sharply lower from a session high of $82.10. The stock has traded in a wide band and was last near the day’s low. The timing is awkward for investors trying to read through the noise around CES launches and a choppy tape for chip names. U.S. markets have been digesting softer labour signals ahead of Friday’s nonfarm payrolls report, a data point that often jolts rate bets and high-growth stocks. Reuters For Ambarella, the
7 January 2026
·····
Varonis Systems (VRNS) stock jumps 8% as Cantor trims target, SaaS shift back in focus

Varonis Systems (VRNS) stock jumps 8% as Cantor trims target, SaaS shift back in focus

New York, Jan 7, 2026, 12:53 EST — Regular session Varonis Systems (VRNS) shares jumped 8.3% to $36.06 by 12:53 EST on Wednesday, after touching $36.49 earlier in the session. The stock closed at $33.30 on Tuesday. The move lands as the Nasdaq was up about 0.7% and investors showed a steadier appetite for risk across tech. Varonis sells data security software that scans, classifies and monitors access to sensitive data across cloud and on-prem systems. Reuters Cantor Fitzgerald on Wednesday cut its price target on Varonis to $50 from $60 but kept an Overweight rating, tying the new target
7 January 2026
····
TORM (TRMD) stock jumps as Oaktree drops below one-third — what changes next

TORM (TRMD) stock jumps as Oaktree drops below one-third — what changes next

NEW YORK, Jan 7, 2026, 12:46 EST — Regular session TORM plc shares jumped 6.7% to $21.85 in midday U.S. trade on Wednesday. The product tanker owner said Oaktree Capital Management and its affiliates have fallen below a one-third ownership threshold, triggering a governance reset. Nasdaq That matters now because the “threshold date” strips out a set of limits written into TORM’s articles of association when Oaktree held a larger stake, leaving the board with wider room to act on certain decisions. The change follows Hafnia’s purchase of shares from Oaktree, which the company had flagged in a December statement.
7 January 2026
····
Workiva stock jumps 5% in regular trade as WK eyes jobs data, CFO switch

Workiva stock jumps 5% in regular trade as WK eyes jobs data, CFO switch

NEW YORK, January 7, 2026, 12:41 ET — Regular session Workiva Inc shares were up about 5.5% at $91.40 on Wednesday, after touching $92.10 earlier in the session. The stock has traded between $86.29 and $92.10 so far, with about 458,000 shares changing hands. The move came as U.S. stocks chopped around after data showed job openings fell more than expected in November, while private payrolls rose less than expected in December. “No one wants to make any outsized bets,” said Kim Forrest, chief investment officer at Bokeh Capital Partners, with investors looking ahead to Friday’s U.S. jobs report. There
7 January 2026
····
Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

New York, January 7, 2026, 12:25 (EST) — Regular session Shares of Adaptive Biotechnologies rose 6.5% to $17.15 on Wednesday, after trading between $16.24 and $17.33, giving the company a market value of about $2.0 billion. The stock has traded between $4.32 and $21.89 over the past 52 weeks. The move matters now because investors have been bidding up riskier biotech names again, and ADPT tends to swing with that tone. The SPDR S&P Biotech ETF and the iShares Nasdaq Biotechnology ETF were each up about 2.5% in midday trade. The broader market was also higher, but not by as
7 January 2026
·····
Vedanta hits fresh 52-week high near Rs 630 on demerger trade; broker targets stretch to Rs 686

Vedanta hits fresh 52-week high near Rs 630 on demerger trade; broker targets stretch to Rs 686

MUMBAI, January 7, 2026, 23:15 (IST) Vedanta Ltd shares touched a 52-week high of 629.90 rupees on Wednesday before giving back most of the move, ending almost flat at 622 rupees. Business Today The jump mattered because it came in a choppy session for Indian stocks, with investors scanning trade and geopolitical headlines ahead of the earnings season. “Markets remain sensitive to trade and geopolitical developments,” said Hitesh Tailor, a research analyst at Choice Equity Broking. Reuters Brokerage targets have moved up as the rally has stretched into a month-long run. Kotak Securities has a target of 650 rupees, Investec
7 January 2026
·····
1 … 382 383 384 385 386 … 882

Stock Market Today

South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop